The effect on esophagus after different radiotherapy techniques for early stage Hodgkin's lymphoma

References

• National Cancer Institute. SEER State Fact Sheets: Hodgkin Lymphoma. SEER Cancer Statistics Review November 2011. [Internet]. Available from: http://seer.cancer.gov/statfacts/html/hodg.html. [cited 2013 Jan 14].
   Google Scholar
• Eich HT, Diehl V, Gorgen H, Pabst T, Markova J, Debus J, et al. Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin’s lymphoma: Final analysis of the German Hodgkin Study Group HD11 trial. J Clin Oncol 2010; 28:4199–206.
   PubMed Web of Science ®Google Scholar
• Engert A, Plutschow A, Eich HT, Lohri A, Dorken B, Borchmann P, et al. Reduced treatment intensity in patients with early-stage Hodgkin’s lymphoma. N Engl J Med 2010; 363:640–52.
   PubMed Web of Science ®Google Scholar
• Aleman BM, van den Belt-Dusebout AW, Klokman WJ, Van’t Veer MB, Bartelink H, van Leeuwen FE. Long-term cause-specific mortality of patients treated for Hodgkin’s disease. J Clin Oncol 2003;21:3431–9.
   PubMed Web of Science ®Google Scholar
• Aleman BM, van den Belt-Dusebout AW, De Bruin ML, van ‘t Veer MB, Baaijens MH, de Boer JP, et al. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 2007;109:1878–86.
   PubMed Web of Science ®Google Scholar
• Ng AK, Bernardo MP, Weller E, Backstrand KH, Silver B, Marcus KC, et al. Long-term survival and competing causes of death in patients with early-stage Hodgkin’s disease treated at age 50 or younger. J Clin Oncol 2002;20:2101–8.
   PubMed Web of Science ®Google Scholar
• Girinsky T, van der Maazen R, Specht L, Aleman B, Poortmans P, Lievens Y, et al. Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: Concepts and guidelines. Radiother Oncol 2006;79:270–7.
   PubMed Web of Science ®Google Scholar
• Maraldo MV, Aznar MC, Vogelius IR, Petersen PM, Specht L. Involved node radiation therapy: An effective alternative in early-stage Hodgkin lymphoma. Int J Radiat Oncol Biol Phys 2013;85:1057–65.
   PubMed Web of Science ®Google Scholar
• Werner-Wasik M, Yorke E, Deasy J, Nam J, Marks LB. Radiation dose-volume effects in the esophagus. Int J Radiat Oncol Biol Phys 2010;76(3 Suppl):S86–93.
   Web of Science ®Google Scholar
• Morton LM, Gilbert ES, Hall P, Andersson M, Joensuu H, Vaalavirta L, et al. Risk of treatment-related esophageal cancer among breast cancer survivors. Ann Oncol 2012; 23:3081–91.
   PubMed Web of Science ®Google Scholar
• Ellenhorn JD, Lambroza A, Lindsley KL, LaQuaglia MP. Treatment-related sophageal stricture in pediatric patients with cancer. Cancer 1993;71:4084–90.
   PubMed Web of Science ®Google Scholar
• Mahboubi S, Silber JH. Radiation-induced esophageal strictures in children with cancer. Eur Radiol 1997;7:119–22.
   PubMed Web of Science ®Google Scholar
• Schiavetti A, Di NG, Ingrosso A, Chiriaco D, Cucchiara S. Barrett esophagus in long-term survivors of childhood solid tumors. J Pediatr Hematol Oncol 2011;33:559–61.
   PubMed Web of Science ®Google Scholar
• Micke O, Schafer U, Glashorster M, Prott FJ, Willich N. Radiation-induced esophageal carcinoma 30 years after mediastinal irradiation: Case report and review of the literature. Jpn J Clin Oncol 1999;29:164–70.
   PubMed Web of Science ®Google Scholar
• Belderbos J, Heemsbergen W, Hoogeman M, Pengel K, Rossi M, Lebesque J. Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy. Radiother Oncol 2005;75:157–64.
   PubMed Web of Science ®Google Scholar
• Alevronta E, Ahlberg A, Mavroidis P, al-Abany M, Friesland S, Tilikidis A, et al. Dose-response relations for stricture in the proximal oesophagus from head and neck radiotherapy. Radiother Oncol 2010;97:54–9.
   PubMed Web of Science ®Google Scholar
• Maraldo MV, Brodin NP, Vogelius IR, Aznar MC, Munck af RP, Petersen PM, et al. Risk of developing cardiovascular disease after involved node radiotherapy versus mantle field for Hodgkin lymphoma. Int J Radiat Oncol Biol Phys 2012; 83:1232–7.
   PubMed Web of Science ®Google Scholar
• Maraldo MV, Brodin NP, Aznar MC, Vogelius IR, Munck af RP, Petersen PM, et al. Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma. Ann Oncol Epub 2013 Apr 25.
   Google Scholar
• Gomez DR, Tucker SL, Martel MK, Mohan R, Balter PA, Lopez Guerra JL, et al. Predictors of high-grade esophagitis after definitive three-dimensional conformal therapy, intensity-modulated radiation therapy, or proton beam therapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2012;84:1010–6.
   PubMed Web of Science ®Google Scholar
• Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine LS, Eisbruch A, et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 2010;76(3 Suppl):S10–9.
   PubMed Web of Science ®Google Scholar
• Lawson JD, Otto K, Grist W, Johnstone PA. Frequency of esophageal stenosis after simultaneous modulated accelerated radiation therapy and chemotherapy for head and neck cancer. Am J Otolaryngol 2008;29:13–9.
   PubMed Web of Science ®Google Scholar
• Ahn SJ, Kahn D, Zhou S, Yu X, Hollis D, Shafman TD, et al. Dosimetric and clinical predictors for radiation-induced esophageal injury. Int J Radiat Oncol Biol Phys 2005;61:335–47.
   PubMed Web of Science ®Google Scholar
• Chudecki B. Radiation cancer of the thoracic oesophagus. Br J Radiol 1972;45:303–4.
   PubMed Web of Science ®Google Scholar
• Fiandra C, Filippi AR, Catuzzo P, Botticella A, Ciammella P, Franco P, et al. Different IMRT solutions vs. 3D-conformal radiotherapy in early stage Hodgkin’s lymphoma: Dosimetric comparison and clinical considerations. Radiat Oncol 2012;7:186.
   PubMed Web of Science ®Google Scholar